246 related articles for article (PubMed ID: 11226154)
1. The endocannabinoid anandamide is a direct and selective blocker of the background K(+) channel TASK-1.
Maingret F; Patel AJ; Lazdunski M; Honoré E
EMBO J; 2001 Jan; 20(1-2):47-54. PubMed ID: 11226154
[TBL] [Abstract][Full Text] [Related]
2. Characterization of four types of background potassium channels in rat cerebellar granule neurons.
Han J; Truell J; Gnatenco C; Kim D
J Physiol; 2002 Jul; 542(Pt 2):431-44. PubMed ID: 12122143
[TBL] [Abstract][Full Text] [Related]
3. Two-pore domain K channel, TASK-1, in pulmonary artery smooth muscle cells.
Gurney AM; Osipenko ON; MacMillan D; McFarlane KM; Tate RJ; Kempsill FE
Circ Res; 2003 Nov; 93(10):957-64. PubMed ID: 14551239
[TBL] [Abstract][Full Text] [Related]
4. Hypoxic depolarization of cerebellar granule neurons by specific inhibition of TASK-1.
Plant LD; Kemp PJ; Peers C; Henderson Z; Pearson HA
Stroke; 2002 Sep; 33(9):2324-8. PubMed ID: 12215606
[TBL] [Abstract][Full Text] [Related]
5. A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery.
White R; Hiley CR
Br J Pharmacol; 1997 Dec; 122(8):1573-84. PubMed ID: 9422801
[TBL] [Abstract][Full Text] [Related]
6. Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation.
Melck D; De Petrocellis L; Orlando P; Bisogno T; Laezza C; Bifulco M; Di Marzo V
Endocrinology; 2000 Jan; 141(1):118-26. PubMed ID: 10614630
[TBL] [Abstract][Full Text] [Related]
7. A role for N-arachidonylethanolamine (anandamide) as the mediator of sensory nerve-dependent Ca2+-induced relaxation.
Ishioka N; Bukoski RD
J Pharmacol Exp Ther; 1999 Apr; 289(1):245-50. PubMed ID: 10087011
[TBL] [Abstract][Full Text] [Related]
8. 5-HT1A receptors increase excitability of spinal motoneurons by inhibiting a TASK-1-like K+ current in the adult turtle.
Perrier JF; Alaburda A; Hounsgaard J
J Physiol; 2003 Apr; 548(Pt 2):485-92. PubMed ID: 12626670
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors.
Felder CC; Joyce KE; Briley EM; Mansouri J; Mackie K; Blond O; Lai Y; Ma AL; Mitchell RL
Mol Pharmacol; 1995 Sep; 48(3):443-50. PubMed ID: 7565624
[TBL] [Abstract][Full Text] [Related]
10. Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors.
Williams CM; Kirkham TC
Psychopharmacology (Berl); 1999 Apr; 143(3):315-7. PubMed ID: 10353436
[TBL] [Abstract][Full Text] [Related]
11. The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons.
Skaper SD; Buriani A; Dal Toso R; Petrelli L; Romanello S; Facci L; Leon A
Proc Natl Acad Sci U S A; 1996 Apr; 93(9):3984-9. PubMed ID: 8633002
[TBL] [Abstract][Full Text] [Related]
12. Anandamide, an endogenous cannabinoid, inhibits Shaker-related voltage-gated K+ channels.
Poling JS; Rogawski MA; Salem N; Vicini S
Neuropharmacology; 1996; 35(7):983-91. PubMed ID: 8938728
[TBL] [Abstract][Full Text] [Related]
13. Acid-sensitive TASK-like K+ conductances contribute to resting membrane potential and to orexin-induced membrane depolarization in rat thalamic paraventricular nucleus neurons.
Doroshenko P; Renaud LP
Neuroscience; 2009 Feb; 158(4):1560-70. PubMed ID: 19135504
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of intestinal motility by anandamide, an endogenous cannabinoid.
Calignano A; La Rana G; Makriyannis A; Lin SY; Beltramo M; Piomelli D
Eur J Pharmacol; 1997 Dec; 340(2-3):R7-8. PubMed ID: 9537804
[TBL] [Abstract][Full Text] [Related]
15. Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide.
Gonsiorek W; Lunn C; Fan X; Narula S; Lundell D; Hipkin RW
Mol Pharmacol; 2000 May; 57(5):1045-50. PubMed ID: 10779390
[TBL] [Abstract][Full Text] [Related]
16. Identification of native rat cerebellar granule cell currents due to background K channel KCNK5 (TASK-2).
Cotten JF; Zou HL; Liu C; Au JD; Yost CS
Brain Res Mol Brain Res; 2004 Sep; 128(2):112-20. PubMed ID: 15363886
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms underlying excitatory effects of group I metabotropic glutamate receptors via inhibition of 2P domain K+ channels.
Chemin J; Girard C; Duprat F; Lesage F; Romey G; Lazdunski M
EMBO J; 2003 Oct; 22(20):5403-11. PubMed ID: 14532113
[TBL] [Abstract][Full Text] [Related]
18. Anandamide-induced mobilization of cytosolic Ca2+ in endothelial cells.
Mombouli JV; Schaeffer G; Holzmann S; Kostner GM; Graier WF
Br J Pharmacol; 1999 Apr; 126(7):1593-600. PubMed ID: 10323591
[TBL] [Abstract][Full Text] [Related]
19. Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain.
Adams IB; Compton DR; Martin BR
J Pharmacol Exp Ther; 1998 Mar; 284(3):1209-17. PubMed ID: 9495885
[TBL] [Abstract][Full Text] [Related]
20. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide.
Zygmunt PM; Petersson J; Andersson DA; Chuang H; Sørgård M; Di Marzo V; Julius D; Högestätt ED
Nature; 1999 Jul; 400(6743):452-7. PubMed ID: 10440374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
